Scott Gottlieb Quotes
More government control of doctors and their reimbursement schemes will only create more problems.
Gottlieb, Scott. "The Doctor Is Out." The Wall Street Journal, 2013.
Actually politicans, civil servants, and private sector individuals who have been working with heath care all knew how complicated health care was. But Trump, who had no experience with health care and its cost and funding structure, when he was a candiate had advisors who were ideologues and had little experience themselves. So Trump campaaigned explaining how simple it was to repeal Obama Care, and replace it with legislation that would cut the insurance premiums, increase the quality of medical care and cover more people while giving consumers protections like no caps and refusals for previous conditions. When he got into office, he discovered that all his campaign ideas would indeed accomplish the objectives that he claimed but it would also mess up other parts of the health system. Nothing could be done in isolation, So he did not repeal Obama Care and made this statement to explain wht he had discovered since assuming office.
He was prophetic. It was the start of the Canadian health system as we know it today. precursor of the New Democratic Party.
Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from 2017 until April 2019. He is presently a resident fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., and a contributor to the cable financial news network CNBC. Before becoming FDA commissioner, he was a clinical assistant professor at New York University School of Medicine, the FDA deputy commissioner for medical and scientific affairs, a venture partner with New Enterprise Associates, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare and Medicaid Services, and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017 prior to joining the FDA as commissioner in May 2017.